You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

21-176

Showing 1 - 25 of 6,357
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC Trial in Seoul (BBT-176, Cetuximab)

Recruiting
  • NSCLC
  • Seongnam-si, Gyeonggi-do, Korea, Republic of
  • +3 more
Jan 6, 2023

SARS-CoV-2 Trial in Chengdu (RBMRNA-176, Placebo)

Active, not recruiting
  • SARS-CoV-2
  • RBMRNA-176
  • Placebo
  • Chengdu, Sichuan, China
    Chengdu Xinhua Hospital affiliated to North Sichuan Medical Coll
Jun 12, 2023

Hyperkalemia Trial in Worldwide (Patiromer, Placebos)

Completed
  • Hyperkalemia
  • Alexander City, Alabama
  • +414 more
Jan 11, 2022

Brain Multifrequency EIT in Healthy People and Brain Diseases

Completed
  • Cerebral Hemorrhage
  • +3 more
  • multifrequency EIT-based for detecting intracranial abnormalities
  • Chongqing, Chongqing, China
    PLA Army Characteristic Medical Center
Mar 31, 2023

Breast Cancer, Cognitive Dysfunction Trial (ICOgnition)

Not yet recruiting
  • Breast Cancer
  • Cognitive Dysfunction
  • ICOgnition
  • (no location specified)
Oct 23, 2023

Solid Tumor Trial in United States (AO-176, AO-176 + Paclitaxel, AO-176 + Pembrolizumab)

Active, not recruiting
  • Solid Tumor
  • Los Angeles, California
  • +9 more
Aug 3, 2022

Anal Fissure Among Survivors of COVID-19 Virus Infection.

Completed
  • Anal Fissure
  • Corona Virus Infection
    • Mansoura, Egypt
      Ahmad
    Feb 22, 2023

    T-cell Lymphomas, NK-Cell Lymphomas Trial in United States (Ruxolitinib, Duvelisib)

    Recruiting
    • T-cell Lymphomas
    • NK-Cell Lymphomas
    • Miami, Florida
    • +8 more
    Aug 1, 2022

    Dermatitis Atopic Trial (Amlitelimab)

    Not yet recruiting
    • Dermatitis Atopic
    • (no location specified)
    Mar 3, 2023

    Metastatic Breast Cancer Trial in Milwaukee (Lifestyle Intervention)

    Recruiting
    • Metastatic Breast Cancer
    • Lifestyle Intervention
    • Attention Control
    • Milwaukee, Wisconsin
      Medical College of Wisconsin
    Dec 16, 2022

    Multiple Myeloma Trial in United States (AO-176, AO-176 + Dex, AO-176 + Dex + Bort)

    Active, not recruiting
    • Multiple Myeloma
    • Phoenix, Arizona
    • +5 more
    Aug 3, 2022

    Higher Risk Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia Trial (AMG 176, Azacitidine)

    Not yet recruiting
    • Higher Risk Myelodysplastic Syndrome
    • Chronic Myelomonocytic Leukemia
    • (no location specified)
    Jul 29, 2022

    Aging Trial in Baton Rouge, Boston, Saint Louis (Caloric Restriction (CR), Control)

    Completed
    Has Results
    • Aging
    • Caloric Restriction (CR)
    • Control
    • Baton Rouge, Louisiana
    • +2 more
    Mar 14, 2022

    COVID-19 Trial in Argentina, Puerto Rico, United States (Bamlanivimab, Etesevimab, Placebo)

    Completed
    Has Results
    • COVID-19
    • Birmingham, Alabama
    • +140 more
    Jun 7, 2022

    Colitis, Ulcerative, IBD Trial in Worldwide (Placebo IV, Placebo SC, Ustekinumab IV)

    Completed
    Has Results
    • Colitis, Ulcerative
    • Inflammatory Bowel Diseases
    • Placebo IV
    • +3 more
    • Birmingham, Alabama
    • +253 more
    Jan 3, 2023

    Survival of Genetically Modified White Blood Cells in

    Active, not recruiting
    • HIV
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Jan 3, 2023

      Influenza Type A, Influenza Type B, Influenza Trial in Austin (SAB-176, Normal Saline)

      Active, not recruiting
      • Influenza Type A
      • +2 more
      • SAB-176
      • Normal Saline
      • Austin, Texas
        PPD, Phase 1 Clinic
      Oct 25, 2021

      Relapsed or Refractory Multiple Myeloma, Relapsed or Refractory Acute Myeloid Leukemia Trial in Worldwide (AMG 176, Azacitidine,

      Recruiting
      • Relapsed or Refractory Multiple Myeloma
      • Relapsed or Refractory Acute Myeloid Leukemia
      • AMG 176
      • +2 more
      • Duarte, California
      • +23 more
      Feb 9, 2022

      NSCLC (NSCLC) Trial (Dacomitinib+Anlotinib, Dacomitinib)

      Not yet recruiting
      • Non-Small Cell Lung Cancer (NSCLC)
      • (no location specified)
      Feb 28, 2022

      Metastatic Microsatellite-stable Colorectal Cancer Trial in China (Experimental drug, Control Rx)

      Recruiting
      • Metastatic Microsatellite-stable Colorectal Cancer
      • Experimental drug
      • Control Rx
      • Hefei, Anhui, China
      • +11 more
      Mar 13, 2023

      Acute Myeloid Leukemia, Non-Hodgkin's Lymphoma, Diffuse Large B-cell Lymphoma Trial in Australia, Germany, United States

      Terminated
      • Acute Myeloid Leukemia
      • +2 more
      • Duarte, California
      • +16 more
      Dec 3, 2021

      Diabetic Foot Trial in Hines, Richmond, Seattle (Remote foot temperature monitoring system, Enhanced usual care)

      Not yet recruiting
      • Diabetic Foot
      • Remote foot temperature monitoring system
      • Enhanced usual care
      • Hines, Illinois
      • +2 more
      Feb 3, 2023

      Influenza A H1N1 Trial in London (SAB-176, Placebo)

      Active, not recruiting
      • Influenza A H1N1
      • SAB-176
      • Placebo
      • London, United Kingdom
        Queen Mary BioEnterprises Innovation Centre
      Oct 25, 2021

      Prostate Cancer Trial (AGN-CognI.Q)

      Recruiting
      • Prostate Cancer
      • Hershey, Pennsylvania
        Penn State Cancer Institute
      Nov 15, 2022

      Acute Myeloid Leukemia Trial in United States (Standard Leukemia Care, Palliative Care)

      Active, not recruiting
      • Acute Myeloid Leukemia
      • Standard Leukemia Care
      • Palliative Care
      • Boston, Massachusetts
      • +3 more
      Jan 24, 2023